Specifically, in untreated MS patients, we found a positive correlation between HLA-DRlow G7 sub-cluster and both vaccine-specific antibody production and S-I-specific CD4+ T cell reactivity (Fig. 6B). The gene discussed is CD4; the disease is myeloid sarcoma.